-
Heterogeneity of Cancer‐Associated Fibroblasts and Precision Targeting Strategies for Cancer Therapy
-
Precision environmental medicine: Integrated multi‐exposure transcriptomics for shared molecular networks in COPD pathogenesis in response to environmental exposure
-
Comprehensive Genomic Profiles of Patients With Biliary Tract Cancer
-
Radiomics and Deep Learning: Bridging Breast Cancer Imaging Phenotypes and Genomic Heterogeneity
-
Traditional Chinese Medicine for lung cancer: Mechanisms, clinical evidence, and future perspectives
-
Stem cell–mediated neuroplasticity and psychological recovery in cancer survivors: Mechanisms, evidence, and translational challenges
-
Salidroside-Based Nanomedicines for Triple-Negative Breast Cancer: From Molecular Mechanisms to Clinical Translation
-
Molecular and genomic advances in breast cancer: A comprehensive review of predictive and therapeutic innovations
-
Genomic determinants and an exploratory prognostic model for immunotherapy outcomes in recurrent or metastatic cervical cancer
-
Single‐cell DNA methylation profiling: Technologies, computation, and applications in precision oncology
-
Clinical Utility of Comprehensive Genomic Profiling for Advanced Non‐Small Cell Lung Cancer: A Single‐Center Retrospective Study
-
Nomogram integrating MRI radiomics and white matter hyperintensity grading for predicting overall survival in patients with non‐small cell lung cancer and brain metastases receiving whole‐brain radiotherapy
-
Exploring biologically-based complementary and alternative medicine use among Irish cancer survivors: findings from a national survey
-
Emerging Agents for Boron Neutron Capture Therapy: Biomolecular Carriers Paving the Way for Precision Radiotherapy
-
Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer
-
Single‐nucleotide polymorphisms in coronary artery disease: Biological complexity, risk architecture, and implications for precision prevention
-
From cytokine storm to renal scarring in diabetic kidney disease: Biomarkers, risk stratification, and precision therapeutics
-
MITF maintains genome stability in nonmelanocyte lineages
-
Correction to “Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors”
-
Harnessing Gut Microbiota to Enhance Immunotherapy in NSCLC: From Mechanisms to Translational Applications
-
Targeted modulation of IGFL2‐AS1 reveals its translational potential in cervical adenocarcinoma
-
The Luo-Dingyuan Thyroid Vascular-Lymphatic Segmentation Classification: A Functional Anatomy-Based Framework to Facilitate Precision Management and Thyroid Function Preservation
-
The Role of Genomics in the Development and Treatment of Multiple Myeloma: Understanding the Challenges and Opportunities
-
Acute lymphoblastic leukemia in adolescents and young adults – from genomics to the clinics
